Related Experiment Video

Updated: Apr 22, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
10:50

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

1.1K

siRNA-Mediated Suppression of Synuclein γ Inhibits MDA-MB-231 Cell Migration and Proliferation by Downregulating the

Jingsong He1, Ni Xie2, Jianbo Yang3

  • 1Department of Breast Surgery, The First Affiliated Hospital of Shenzhen University, Second People's Hospital of Shen Zhen, Shen Zhen, China.

Journal of Breast Cancer
|October 17, 2014
PubMed
Abstract

Insights

Synuclein-γ (SNCG) siRNA treatment significantly reduced breast cancer cell migration and proliferation. This occurred by downregulating the phosphorylation of AKT and ERK signaling pathways, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Synuclein-γ (SNCG) is highly expressed in advanced breast cancers but not normal tissues.
  • SNCG was initially identified as breast cancer specific gene 1.
  • Understanding SNCG's role is crucial for targeted breast cancer therapies.

Purpose of the Study:

  • To evaluate the effects of SNCG siRNA treatment on breast cancer cells.
  • To elucidate the molecular mechanisms underlying SNCG's role in breast cancer.
  • To investigate SNCG siRNA's impact on cell proliferation, migration, apoptosis, and cell cycle.

Main Methods:

  • Transfection of MDA-MB-231 cells with SNCG siRNA and negative control (NC) siRNA.
  • Quantification of mRNA levels using real-time polymerase chain reaction.
  • Assessment of cell proliferation (MTT assay), migration (Transwell assay), apoptosis, and cell cycle (flow cytometry).
  • Western blot analysis to determine protein levels of AKT, ERK, p-AKT, and p-ERK.

Main Results:

  • SNCG siRNA significantly reduced SNCG mRNA levels in MDA-MB-231 cells.
  • SNCG siRNA treatment led to decreased cell migration and proliferation.
  • Apoptosis was induced, and cell cycle arrest was observed in SNCG siRNA-treated cells.
  • Phosphorylation levels of AKT (p-AKT) and ERK (p-ERK) were significantly reduced.

Conclusions:

  • SNCG siRNA effectively inhibits breast cancer cell migration and proliferation.
  • The mechanism involves the downregulation of AKT and ERK phosphorylation.
  • SNCG siRNA represents a potential therapeutic approach for breast cancer treatment.
Keywords:
Breast neoplasmsExtracellular signal-regulated MAP kinasesHuman SNCG proteinProto-oncogene proteins c-aktSmall interfering RNA

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K